An analysis of data from the REPRIEVE statin trial found that metabolic risk factors strongly contributed to the increased cases of new-onset diabetes among people with HIV (PWH).
news, journals and articles from all over the world.
An analysis of data from the REPRIEVE statin trial found that metabolic risk factors strongly contributed to the increased cases of new-onset diabetes among people with HIV (PWH).